Brainstorm Cell Therapeutics Inc.
BCLIOTCHealthcare● Active
$0.80
+$0.05(+6.87%)
Market Cap$8827820
P/E Ratio—
52W High$1.33
52W Low$0.46
Brainstorm Cell Therapeutics Inc. (BCLI) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BCLI · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.02B |
| Net Receivables | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Inventory | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Current Assets | $0.00B | $0.00B | $0.00B | $0.00B | $0.02B |
| PP&E Net | $0.00B | $0.00B | $0.00B | $0.01B | $0.01B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Assets | $0.00B | $0.00B | $0.00B | $0.01B | $0.03B |
| Liabilities | |||||
| Short-Term Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Accounts Payable | $0.01B | $0.01B | $0.00B | $0.01B | $0.00B |
| Total Current Liabilities | $0.01B | $0.01B | $0.01B | $0.01B | $0.01B |
| Long-Term Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Liabilities | $0.01B | $0.01B | $0.01B | $0.01B | $0.01B |
| Stockholders Equity | |||||
| Retained Earnings | ($0.24B) | ($0.23B) | ($0.22B) | ($0.20B) | ($0.17B) |
| Total Stockholders Equity | ($0.01B) | ($0.01B) | ($0.00B) | ($0.00B) | $0.02B |
| Total Liab & Equity(computed) | $0.00B | $0.00B | $0.00B | $0.01B | $0.03B |
| Debt Summary | |||||
| Total Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.01B |
| Net Debt | $0.00B | $0.00B | ($0.00B) | $0.00B | ($0.01B) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Brainstorm Cell Therapeutics Inc. data
About Brainstorm Cell Therapeutics Inc. (BCLI) Balance Sheet
Brainstorm Cell Therapeutics Inc. (BCLI) balance sheet shows total assets of $0.00B with cash of $0.00B. Total liabilities are $0.01B, total debt $0.00B, and stockholders equity ($0.01B).
Frequently asked questions
BCLI · 4 questionsBrainstorm Cell Therapeutics Inc. has total debt of $0.00B with net debt of $0.00B.
BCLI total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10